>60

The Vaccine Alliance has helped to strengthen health systems and immunisation services in more than 60 countries.

Source: Gavi

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Source: Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

>1.5 million

Since the first human papillomavirus (HPV) vaccine demonstration programme in Kenya in 2013, more than 1.5 million girls have been immunised with Gavi support.

Source: WHO/UNICEF and Gavi 2018

≈400

Gavi has supported close to 400 vaccine introductions and campaigns since 2000.

Source: Gavi

>18 million

Since its creation in 2013, the Gavi-supported global oral cholera vaccine stockpile has distributed over 18 million doses to 18 countries. In 2017, nine countries – Bangladesh, Cameroon, Haiti, Malawi, Mozambique, Nigeria, Sierra Leone, Somalia and South Sudan – accessed the stockpile.

Source: Gavi

>100 million

Since 2011, Gavi-supported campaigns have protected over 98 million people in 14 countries. We have also helped 17 countries introduce yellow fever vaccine through routine immunisation, immunising more than 100 million children.

Source: WHO/UNICEF Gavi 2018

52 million

Since 2007, countries have immunised 52 million children with a second dose of measles vaccine and 15 million with a first dose of measles-rubella vaccine through Gavi-supported routine immunisation programmes. Gavi-funded campaigns with these two vaccines have helped to vaccinate another 370 million children in countries at high risk of outbreaks.

Source: WHO/UNICEF and Gavi 2018

75 million

In September 2014, Nepal became the first country to introduce inactivated polio vaccine (IPV) with Gavi support. By the end of 2017, 55 countries had introduced the vaccine with our support, collectively immunising more than 75 million children.

Source: WHO/UNICEF and Gavi 2018

65 million

In 2017 alone, 65 million children were immunised with Gavi-supported vaccines. This equates to more than 190 million points of contact between these children and the primary health system and provides a robust platform for other health interventions.

Source: WHO/UNICEF 2018

19.9 million

19.9 million infants remain underimmunised with three doses of DTP in the world each year. One in five of all children in Gavi-supported countries miss out on a full course of this basic package of vaccines.

Source: WHO/UNICEF 2018

1.5 million

In 2012, approximately 6.6 million children died before the age of five. WHO estimates that 1.5 million of these deaths are due to vaccine-preventable diseases.

Source: WHO

48%

The weighted average price of pentavalent vaccine per dose dropped from US$ 2.98 in 2010 to US$ 1.55 in 2016, and is expected to decrease further to US$ 0.79 by 2019.

Source: Gavi

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Source: Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016.

>143 million

By the end of 2017, 58 countries had immunised more than 143 million children against pneumococcal disease with support from the Vaccine Alliance.

Source: WHO/UNICEF and Gavi 2018

>690 million

Since 2000, Gavi support has contributed to the immunisation of more than 690 million children.

Source: WHO/UNICEF 2018

Every two minutes

One woman dies from cervical cancer every two minutes – or 266,000 a year – over 80% in developing countries. If current trends hold, and without changes in prevention and control, cervical cancer deaths could eventually outpace maternal deaths. HPV vaccines can prevent up to 90% of all cervical cancer cases.

Source: WHO

7%

Only 7% of children in Gavi-supported countries have access to all 11 vaccines recommended by WHO for infants in all countries.

Source: WHO/UNICEF, UNDP 2017

>279 million

By the end of 2017, 21 countries in the African meningitis belt had immunised over 279 million people against meningitis A through Gavi-supported campaigns. Seven countries had introduced the vaccine into their national immunisation systems.

Source: WHO/UNICEF and Gavi 2018

20 by 2020

Gavi continues to help countries to build sustainable immunisation programmes. Sixteen countries have already started to fully self-finance all their vaccines introduced with Gavi funding. By the end of 2020, a total of 20 countries are expected to have transitioned out of our support.

Source: Gavi

>10 million

Since its inception in 2000, Gavi has helped developing countries to prevent more than 10 million future deaths through its support for routine immunisation programmes and vaccination campaigns.

Source: WHO/UNICEF and Gavi 2018

close icon

modal window here